Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.
N/A
The RELATIVITY study is a nationwide, multicenter, ambispective observation...
Status
Active Not Recruiting
Location
Hospital Universitario de Burgos
Start Date
2024-12-31
Trial ID
NCT07703748
Implementing Long-Acting Novel Antiretrovirals
N/A
This is a 12-month, dual arm, phase 4, open-label, multi-centre study exami...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
PHASE3
The Antiretroviral Therapy as Long Acting Suppression (ATLAS) study is bein...
A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
PHASE3
This is a multicentre study carried out in participants living with human i...